Amy Baxter
Staff ReporterAmy Baxter is a staff reporter for PharmaVoice. Before joining the team, she served as an editor and reporter in the B2B healthcare space for eight years at Health Exec and Home Health Care News. She also covered the retail industry as editor of Retail Leader, and hosted an Hermes award-winning weekly podcast and video interview series, Trend Talk, featuring industry executives and experts. A lifelong sailor, Amy has taken her media skills on the water to cover regattas and sailing events across the country. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Race to Mackinac Island. She is based in Florida.
18 articles by Amy Baxter
-
AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy
April 24, 2024 -
WuXi partnerships at risk as lawmakers target Chinese ties to biopharma
April 22, 2024 -
3 patent expirations in 2024 and how companies are pivoting
April 17, 2024 -
Where the GLP-1 weight loss market goes will depend on data
April 15, 2024 -
What’s old is new: The revival of a one-time radiotherapy cancer treatment
April 10, 2024 -
Cutting pills. Rationing insulin. How Americans struggle to pay for drugs.
April 9, 2024 -
As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene
April 3, 2024 -
To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach
March 29, 2024 -
Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
March 27, 2024 -
With historic MASH approval, Madrigal preps for launch and a public offering
March 20, 2024 -
5 Big Pharma CEOs who saw major pay bumps in 2023
March 18, 2024 -
These biotech hotspots are ripe for IPOs
March 13, 2024 -
COVID vaccine giants Moderna and Pfizer employ divergent tactics for the next chapter
March 11, 2024 -
Could pharma’s legal attack on the IRA succeed in killing price negotiations?
March 6, 2024 -
After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections
March 1, 2024 -
For Moderna, COVID vaccines were a ‘proof of concept’ — now comes the big test
Feb. 23, 2024 -
Pharma CFOs need R&D vigilance in tough economic times
Feb. 16, 2024 -
FDA inches closer to defining its regulatory role in AI
Feb. 12, 2024